Personale docente

David Sacerdoti

Professore associato confermato

MED/09

Indirizzo: VIA GIUSTINIANI, 2 - PADOVA . . .

Telefono: 0498212300

Fax: 0498218292

E-mail: david.sacerdoti@unipd.it

Born: March 20, 1956 - Padova,Italy

EDUCATION:
University of Padova, Italy 1974-1980
Doctor of Medicine (Laurea)
University of Padova, Italy, School of Specialization in 1980-1985
Internal Medicine, Specialist in Internal Medicine
University of Padova, Italy, School of Specialization in 1985-1990
Cardiology, Specialist in Cardiology
MILITARY SERVICE:
Medical Officer, Military Hospital, Trieste and Padova 1981-1982
CLINICAL AND RESEARCH POSITIONS:
Resident in Medicine University Hospital, Padova, Italy 1980-1981
Fellow in Internal Medicine, University Hospital, Padova, Italy 1981-1985
Fellow in Cardiology, University Hospital, Padova, Italy 1985-1990
Assistant Professor, Internal Medicine, University Hospital, Padova, Italy 1990-2005
Associate Professor, Internal Medicine, University of Padova, Italy 2005-pres
N.A.T.O. Fellow, Dept. of Pharmacology, 1985
New York Medical College, Valhalla, N.Y., U.S.A.
Fogarty International Fellow, Dept. Of Pharmacology, 1985-1986
New York Medical College, Valhalla, N.Y., U.S.A.
Adjunct Assistant Professor, Dept. Of Pharmacology, 1988-pres
New York Medical College, Valhalla, N.Y., U.S.A.
ACADEMIC POSITIONS:
Instructor in Medicine, University of Padova, Italy 1980-1987
Adjunct Professor, School of Specialization in Nephrology, 1987-2003
University of Padova, Padova, Italy
Adjunct Professor, School of Specialization in Internal Medicine 1991-2005
University of Padova, Padova, Italy
Adjunct Assistant Professor, Department of Pharmacology, 1988-pres
New York Medical College, USA
Associate Professor, Internal Medicine, University of Padova, Italy 2005-pres
Director, School of Specialization in Gerontology, 2013-pres
University of Padova, Italy
AWARDS:
Italian Society of Internal Medicine Award 1985
N.A.T.O. Fellowship 1985
Fogarty Fellowship 1985-1986
SUMMARY OF RESEARCH INTERESTS
Portal hypertension. Hemodynamic alterations of cirrhosis and pharmacodynamics.
Doppler-sonography of the liver and the splanchnic circulation. Diabetes. The heme-oxygenase/carbon monoxide system in hypertension and liver pathophysiology. Cytochrome P450-dependent arachidonic acid metabolites in hypertension and liver pathophysiology. Non-alcoholic fatty liver disease.
GRANTS:
Italian Ministry of Research (MIUR), Regione Veneto, Italy, National Heart, Lung, and Blood Institute of USA (NHLBI), US, National Council for Reserch of Italy (CNR).
PUBLICATIONS:
134 papers published in Journals cited by PubMed (Science, Journal of Clinical
Investigation, Lancet, Gastroenterology, Hepatology, American Journal of Physiology,
Kidney International, Journal of Hepatology, Diabetes, American Heart Journal, Archives
of Internal Medicine, American Journal of Gastroenterology, Hypertension etc), with an impact factor of >700. H index: 37.
EDITORIAL DUTIES
Guest Editor of “Prostaglandins and Other Lipid Mediators” 2003: “Eicosanoid-dependent mechanisms in liver disease”.
Guest Editor of “International J Hypertension” 2012: “The emerging role of Heme-oxygenase and its metabolites in the regulation of cardiovascular function”.
Guest editor of “Prostaglandins and Other Lipid Mediators” 2012: “Eicosanoids in Cardiovascular Disease”.
Guest Editor of “Prostaglandins and Other Lipid Mediators” 2015: “Eicosanoids and related Compounds”.
Editorial Board:
Frontiers in Pharmacology (Associate Editor), J. Ultrasound

Download Curriculum_Sacerdoti.pdf


PUBLICATIONS:
134 papers published in Journals cited by PubMed (Science, Journal of Clinical
Investigation, Lancet, Gastroenterology, Hepatology, American Journal of Physiology,
Kidney International, Journal of Hepatology, Diabetes, American Heart Journal, Archives
of Internal Medicine, American Journal of Gastroenterology, Hypertension etc), with an impact factor of >700. H index: 37.
EDITORIAL DUTIES
Guest Editor of “Prostaglandins and Other Lipid Mediators” 2003: “Eicosanoid-dependent mechanisms in liver disease”.
Guest Editor of “International J Hypertension” 2012: “The emerging role of Heme-oxygenase and its metabolites in the regulation of cardiovascular function”.
Guest editor of “Prostaglandins and Other Lipid Mediators” 2012: “Eicosanoids in Cardiovascular Disease”.
Guest Editor of “Prostaglandins and Other Lipid Mediators” 2015: “Eicosanoids and related Compounds”.
Editorial Board:
Frontiers in Pharmacology (Associate Editor), J. Ultrasound

Download Pubblicazioni_Sacerdoti.pdf

Portal hypertension.
Hemodynamic alterations of cirrhosis and pharmacodynamics.
Doppler-sonography of the liver and the splanchnic circulation.
Diabetes.
The heme-oxygenase/carbon monoxide system in hypertension and liver pathophysiology.
Cytochrome P450-dependent arachidonic acid metabolites in hypertension and liver pathophysiology.
Non-alcoholic fatty liver disease.